XBP1 and neoplasm: Low expression of XBP1, including XBP1s and XBP1u (downstream targets of IRE1), can inhibit the Warburg effect in prolactinoma GH3 cells by downregulating PKM2, and fulvestrant exerts its tumor-suppressive effects through this pathway [127].